First trial over Zantac cancer claims set to begin in Chicago [Reuters]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Reuters
Jury selection began on Tuesday before Judge Daniel Trevino of the Circuit Court of Cook County, with lawyers' opening statements expected to follow. GSK is the sole defendant in the trial, after other companies settled. The plaintiff, 89-year-old Illinois resident Angela Valadez, that she developed colorectal cancer as a result of taking over-the-counter Zantac and generic versions of it from 1995 to 2014. Like other plaintiffs suing over the drug, she says its active ingredient, ranitidine, as it ages turns into a cancer-causing substance called NDMA. "We're happy that she's getting her day in court," said Ashley Keller a lawyer for Valadez. Her case is one of tens of thousands against GSK and other companies including Pfizer , Sanofi and Boehringer Ingelheim, which have in recent years. It will offer the first test of whether the cancer claims will persuade a jury, since all cases previously set for trial settled or were dropped. The drugmakers have maintained that Zantac
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead? [Yahoo! Finance]Yahoo! Finance
- Immersive Labs Unveils New ‘Dark Side of GenAI' Report about How People Trick Chatbots into Exposing Company Secrets [Yahoo! Finance]Yahoo! Finance
- Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now [Yahoo! Finance]Yahoo! Finance
- AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030 [Fortune]Fortune
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- 5/9/24 - Form S-8
- PFE's page on the SEC website